Clinical trials
Phase 4 Hyperglycemia trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
81 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2002 | 1 |
| 2004 | 4 |
| 2005 | 7 |
| 2006 | 4 |
| 2007 | 4 |
| 2008 | 4 |
| 2009 | 5 |
| 2010 | 7 |
| 2011 | 2 |
| 2012 | 2 |
| 2013 | 4 |
| 2014 | 8 |
| 2015 | 2 |
| 2016 | 8 |
| 2017 | 3 |
| 2018 | 3 |
| 2019 | 2 |
| 2020 | 2 |
| 2021 | 2 |
| 2024 | 3 |
| 2025 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 58 |
| Unknown status | 13 |
| Terminated | 5 |
| Recruiting | 3 |
| Active, not recruiting | 1 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Emory University | 7 |
| Northwestern University | 3 |
| Novartis Pharmaceuticals | 3 |
| University of Guadalajara | 3 |
| Baylor College of Medicine | 2 |
| Cook County Health | 2 |
| Nathan Kline Institute for Psychiatric Research | 2 |
| Beni-Suef University | 1 |
| Birjand University of Medical Sciences | 1 |
| Brigham and Women's Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hyperglycemia | 81 |
| Diabetes Mellitus, Type 2 | 27 |
| Diabetes Mellitus | 23 |
| Insulin Resistance | 15 |
| Hypoglycemia | 11 |
| Diabetes Mellitus, Type 1 | 5 |
| Critical Illness | 4 |
| Glucose Intolerance | 4 |
| Obesity | 4 |
| Prediabetic State | 4 |
Trials
Showing 51 to 75 of 81. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.